Genprex, Inc. Gains 39.07%
Tue, Jan 07, 2020 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) soared at $0.42, representing a gain of 39.1%. On Mon 06 Jan 20, GNPX:NASDAQ touched a New 2-Week Intraday High of $0.33. The stock got featured on our News Catalysts scanner on Mon 06 Jan 20 at 08:36 AM in the 'MISCELLANEOUS' category. From Fri 13 Dec 19, the stock recorded 50.00% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Genetic Technologies Limited (GENE:NASDAQ), 120%
- Cellect Biotechnology Ltd. (APOP:NASDAQ), 70.42%
- Camber Energy, Inc. (CEI:NYSEMKT), 41.55%
- Genprex, Inc. (GNPX:NASDAQ), 39.07%
- U.S. Energy Corp. (USEG:NASDAQ), 28.32%
- Apellis Pharmaceuticals, Inc. (APLS:NASDAQ), 28.29%
- Waitr Holdings Inc. (WTRH:NASDAQ), 27.77%
- Gulf Resources, Inc. (GURE:NASDAQ), 27.53%
- Apache Corporation (APA:NYSE), 26.79%
- AzurRx BioPharma, Inc. (AZRX:NASDAQ), 25.71%